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IL-22 Promotes Fibroblast-Mediated Wound Repair
in the Skin
Heather M. McGee1,2, Barbara A. Schmidt1, Carmen J. Booth3, George D. Yancopoulos4,
David M. Valenzuela4, Andrew J. Murphy4, Sean Stevens4,5, Richard A. Flavell2,6 and Valerie Horsley1,6
Skin wound repair requires complex and highly coordinated interactions between keratinocytes, fibroblasts, and
immune cells to restore the epidermal barrier and tissue architecture after acute injury. The cytokine IL-22
mediates unidirectional signaling from immune cells to epithelial cells during injury of peripheral tissues such as
the liver and colon, where IL-22 causes epithelial cells to produce antibacterial proteins, express mucins, and
enhance epithelial regeneration. In this study, we used IL-22 / mice to investigate the in vivo role for IL-22 in
acute skin wounding. We found that IL-22 / mice displayed major defects in the skin’s dermal compartment
after full-thickness wounding. We also found that IL-22 signaling is active in fibroblasts, using in vitro assays with
primary fibroblasts, and that IL-22 directs extracellular matrix (ECM) gene expression and myofibroblast
differentiation both in vitro and in vivo. These data define roles of IL-22 beyond epithelial cross talk, and
suggest that IL-22 has a previously unidentified role in skin repair by mediating interactions between immune
cells and fibroblasts.
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INTRODUCTION
Breaches to epithelial barriers such as the skin result in an
inflammatory response that prevents infection and augments
tissue repair via the release of cytokines that signal between
the immune system and cells in the damaged tissue (Eming
et al., 2007; Barrientos et al., 2008). In the skin, wound repair
requires interactions between keratinocytes, fibroblasts, immune
cells, and endothelial cells. Communication between these cells
restores the epithelial barrier via keratinocyte proliferation and
migration while reestablishing the dermal architecture through
extracellular matrix (ECM) production and myofibroblast-
mediated wound contraction.
Members of the IL-10 cytokine family are soluble factors
that orchestrate interactions between the immune system and
peripheral tissues (Dumoutier et al., 2001; Kotenko, 2002).
One member of the IL-10 cytokine family, IL-22, is produced
by both adaptive and innate lymphoid cells (Liang et al., 2006;
Cella et al., 2009; Cupedo et al., 2009; Eyerich et al., 2009;
Goto et al., 2009; Martin et al., 2009; Takatori et al., 2009). IL-
22 mediates its functions in tissues by binding to its
heterodimeric receptor consisting of IL-10 receptor b (IL-
10Rb) and IL-22 receptor a (IL-22Ra) and activating
signaling pathways that stimulate STAT3 phosphorylation
and nuclear translocation (Xie et al., 2000; Dumoutier et al.,
2001, 2003; Kotenko et al., 2001; Lejeune et al., 2002).
Whereas IL-10Rb is expressed ubiquitously on both immune
cells and tissue-specific cell types, IL-22Ra is thought to be
exclusively expressed on epithelial cells, such as keratinocytes
in the skin and hepatocytes in the liver (Dumoutier et al.,
2003; Radaeva et al., 2004; Wolk et al., 2004). The restriction
of IL-22Ra expression allows IL-22 to mediate unidirectional
signaling from the immune system to tissue-specific cells.
Many similarities can be found between the repair pro-
cesses that occur in the skin and those that occur in other
organs containing epithelium, such as the thymus, liver, and
intestine, where IL-22 mediates signaling to epithelial cells
(Radaeva et al., 2004; Zenewicz et al., 2007, 2008; Sasaki
et al., 2011; Dudakov et al., 2012). In the skin, IL-22 is
expressed after burn wounding (Sasaki et al., 2011), elevated
in human psoriasis patients (Lowes et al., 2008), and promotes
dermal inflammation (Zheng et al., 2007; Ma et al., 2008;
Zhang et al., 2012). In vitro studies have suggested that IL-22
signals to epithelial keratinocytes of the skin to promote
proliferation and migration while repressing keratinocyte
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differentiation (Boniface et al., 2005; Wolk et al., 2006);
however, the function of IL-22 in vivo during acute skin
wound healing has not been explored.
In this study, we investigated the role of IL-22 in a murine
model of acute skin wounding. We find that IL-22 messenger
RNA (mRNA) is upregulated during the inflammatory response
following tissue injury. Surprisingly, keratinocytes in the skin
of IL-22 / mice display only minor defects in their ability to
repair the epithelial barrier during wound healing. However,
IL-22 / wounds exhibit severe defects in the dermal com-
partment because of deficiencies in fibroblast function. We
show that IL-22-induced signaling in fibroblasts regulates ECM
production and myofibroblast differentiation during proper
wound healing. Therefore, our results demonstrate that IL-22
mediates signaling beyond epithelial cells and is required for
normal fibroblast function during skin wound repair.
RESULTS
IL-22 mRNA expression during acute skin wounding
To determine whether IL-22 might have a role in acute skin
wounding, we analyzed the expression of IL-22 and IL-22Ra
mRNA in a murine model of full-thickness skin wounds. The
dorsal skin of wild-type (WT) mice was wounded using 2- or
8-mm skin punch biopsies as indicated. For each wound size,
wounds were harvested during and after the inflammatory
phase of wound healing, as indicated by CD45 mRNA and
protein expression in 3-day skin wounds of 2-mm biopsies
(referred to as small wounds) and in 5-day skin wounds of
8-mm biopsies (referred to as large wounds; Figure 1a and data
not shown; Eming et al., 2007). IL-22 mRNA was not detected
in unwounded skin (Figure 1b). However, IL-22 mRNA was
upregulated during the inflammatory phase of wound healing,
and its expression returned to a steady state after inflammation
(Figure 1b). In contrast, IL-22Ra mRNA expression increased
only slightly during the inflammatory phase compared with
unwounded skin, but its expression returned to baseline levels
after inflammation (Figure 1c). These data are consistent with
the induction of IL-22 mRNA expression after infectious or
injurious stimuli in the liver and colon (Radaeva et al., 2004;
Zenewicz et al., 2007, 2008). Taken together, these data
demonstrate that IL-22 signaling components are expressed in
the skin during acute wound healing.
Delayed wound healing in IL-22 / mice
As IL-22 mRNA expression is upregulated in the skin after
wounding, we investigated whether acute wound healing was
defective in IL-22 / mice. No overt skin defects were
observed in IL-22 / mice during development (data not
shown) or in adult mice (Supplementary Figure S1a online). To
investigate whether IL-22 has a role in wound healing in vivo,
we generated small and large full-thickness wounds in the
dorsal skin of sex-matched WT and IL-22 / mice during the
telogen phase of the hair cycle (Supplementary Figure S1a
online). Immune cell recruitment and blood vessel formation
were similar between wounds of WT and IL-22-null mice, as
indicated by the expression of CD45 and isolectin GS-IB4
(Tammela et al., 2008), respectively (Supplementary Figure
S2a and b online).
Surprisingly, keratinocyte function during wound healing
was not significantly impaired in IL-22-null mice in this
wound model, as indicated by the lack of defects in epidermal
area (Supplementary Figure S1b online), proliferation of
keratinocytes in the leading edge (Supplementary Figure S1c
and d online), and rates of reepithelialization (Supplementary
Figure S1e online). In addition, induction of the antimicrobial
protein, cathelicidin (Dorschner et al., 2001), occurred
normally in IL-22-null wounds despite the ability of IL-22 to
regulate antimicrobial gene expression (Liang et al., 2006;
Supplementary Figure S2c online).
In contrast, a major difference in external wound area and
the appearance of the dermal compartment was noted in both
small and large wounds of IL-22 / mice. In WT mice, the
external area of small wounds was B1.2 103mm2 at day 3,
and it decreased to B500mm2 by day 5. In contrast, the
average external area of small wounds in IL-22 / mice was
B2 103mm2 at day 3, and it decreased slightly to
B1.5103mm2 at day 5 (Figure 2a). Morphometric analysis
of hematoxylin and eosin–stained sections from 2- or 8-mm
wounds of WT and IL-22 / mice post injury revealed a
striking defect in the dermis of IL-22 / mice. The area
underneath the wound, referred to as wound bed area, was
decreased in both small and large wounds (Figure 2b).
Furthermore, hematoxylin and eosin–stained sections revealed
alterations in the organization of the dermal compartment of
both small and large wounds in IL-22 / mice (Figure 2b and
data not shown).
Defects in extracellular matrix production in IL-22 / mice
To determine whether the reduced wound bed area in
IL-22 / mice was due to defects in ECM production, we
analyzed skin sections of WT and IL-22 / mice using
histological stains: Movat pentachrome to reveal total collagen
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Figure 1. IL-22 messenger RNA (mRNA) is expressed during acute skin wounding. (a) CD45, (b) IL-22, and (c) IL-22Ra mRNA expression via real-time PCR in
unwounded skin or wounds of mice after the indicated time points. n¼ 3 wounds from three mice for each time point. All data are±SEM. Asterisks indicate
significance.
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and Sirius Red to stain collagen type III. During the inflam-
matory phase of wound healing, collagen was localized
adjacent to the wound bed and was decreased in IL-22 /
mice (Figure 3a). After inflammation, collagen localization in
IL-22 / wounds resembled that of WT wounds at day 3,
suggesting a delay in collagen production in the absence of IL-
22 (Figure 3a). Moreover, Sirius Red staining revealed that
Collagen Type III fibers were disorganized in IL-22 / mice
at day 28 in the remodeling phase of wound healing.
To determine whether the reduction in collagen protein
content in IL-22 / skin results from defects in the transcrip-
tion of ECM genes, we analyzed Fibronectin, Collagen Type
IaI, and Collagen Type IIIaI mRNA expression from WT
and IL-22 / skin post wounding (Figure 3b). Wound
healing in WT mice was characterized by an initial upregula-
tion of Fibronectin and Collagen Type IIIaI mRNAs during
inflammation, but these gene products decreased after the
inflammatory phase. In contrast, Collagen Type IaI mRNA
levels increased and remained elevated during these time
points in WT mice. Our data show that the levels of
Fibronectin, Collagen Type IaI, and Collagen Type IIIaI were
significantly reduced in IL-22 / skin compared with
WT skin (Figure 3b). Therefore, delayed wound healing in
IL-22 / mice is consistent with a delay in the expression of
ECM genes during wound healing.
Considering that ECM components are produced by fibro-
blasts within the dermis, we hypothesized that fibroblast
number or ECM production was decreased in IL-22 / mice.
To determine whether IL-22 affects the number of fibroblasts,
we isolated WT and IL-22 / dermal cells from unwounded
skins and from skins post wounding. Using flow cytometry, we
analyzed the percentage of fibroblasts by staining dermal cells
with an antibody against the fibroblast-specific protein ER-TR7
(Van Vliet et al., 1984). We found no significant difference in
the percentage of ER-TR7þ fibroblasts isolated from IL-22 /
wounds compared with WT wounds (Figure 3c).
To confirm that the dermal defects are due to an absence of
IL-22 during dermal remodeling, we injected recombinant IL-
22 intradermally into IL-22 / wounds 3 days after wounding
when the initial defects in the dermis are detected in IL-22 /
mice. The severe defect in collagen production in IL-22 /
mice was restored by intradermal IL-22 (Figure 3d). This result
confirms that IL-22 is essential for proper dermal organization
after wounding.
IL-22 activates extracellular matrix gene expression in fibroblasts
To determine whether IL-22 acts directly on fibroblasts during
wound healing, TaqMan real-time PCR was used to measure
IL-22Ra expression in FACS-purified murine keratinocytes,
naive CD4þCD25CD44CD62Lþ T cells, and purified
dermal fibroblasts (Kunz et al., 2006; Festa et al., 2011). We
used real-time PCR to determine the purity of the isolated
keratinocyte and fibroblast populations on the basis of K14
and vimentin mRNA expression (Supplementary Figure S3b
online). As expected, IL-22Ra mRNA was not detected in
naive T cells, but was expressed in keratinocytes (Kunz et al.,
2006; Figure 4a). Surprisingly, IL-22Ra mRNA was also
expressed in fibroblasts. This expression was confirmed by
immunostaining with antibodies against ER-TR7 and IL-22Ra
in skin sections (Figure 4b). Specificity of the IL-22Ra staining
was confirmed by immunostaining with rabbit isotype control
antibodies (Supplementary Figure S3c online).
To determine whether IL-22 can activate signaling down-
stream from IL-22Ra in fibroblasts, we analyzed STAT3
phosphorylation, as IL-22 induces STAT3 phosphorylation
and nuclear translocation in other cell types (Lejeune et al.,
2002). Primary fibroblasts were serum-starved and then
stimulated for 20 minutes with vehicle, Oncostatin M, which
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Figure 2. IL-22 / mice exhibit defects in the dermis during wound healing. (a) Images of wild-type (WT) and IL-22 / back skin 3 days after wounding
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activates STAT3 in fibroblasts (Snyder et al., 2008), or
recombinant IL-22. Immunostaining of fibroblasts with
antibodies against phosphorylated STAT3 (STAT3-P) revealed
activation of STAT3 after stimulation with either OSM or IL-22
(Figure 4d). Western blot analysis of fibroblast cell lysates after
OSM or IL-22 stimulation confirmed that IL-22 stimulates
phosphorylation of STAT3 in fibroblasts (Figure 4c). Taken
together, these data demonstrate that fibroblasts express
functional IL-22Ra and that IL-22/IL-22Ra signaling is suffi-
cient to activate STAT3-P in fibroblasts.
To determine whether IL-22 can directly stimulate the
production of the ECM components in fibroblasts, primary
cultured dermal fibroblasts isolated from WT or IL-22-null
mice were stimulated with recombinant IL-22 for 48 hours.
We analyzed mRNA expression by real-time PCR. IL-22
induced a dose-dependent increase in mRNA expression of
Fibronectin, Collagen Type IaI, and Collagen Type IIIaI, but
not Integrin a5 or Metalloproteinase 9, which mediate
adhesion to or degradation of ECM molecules, respectively
(Figure 4e; Sawicki et al., 2005; Liu et al., 2010). As IL-22 /
fibroblasts also induce ECM genes in response to IL-22, no
intrinsic defects exist in the fibroblasts from IL-22 / mice.
These changes in gene expression were confirmed by western
blot analysis of fibronectin protein expression after IL-22
stimulation (Figure 4f). Taken together, these data suggest that
IL-22 signaling in fibroblasts can directly induce the expres-
sion of ECM components.
IL-22 activates myofibroblast differentiation
As IL-22 / mice display defects in wound contraction and
ECM production after wounding, we hypothesized that IL-22
may influence the differentiation of dermal myofibroblasts,
which contract wounds and produce ECM during wound
healing (Montesano and Orci, 1988). Myofibroblasts are
identified by their characteristic expression of a-smooth
muscle actin (a-SMA; Darby et al., 1990). To determine
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whether the skin of IL-22 / mice displays a reduction in the
number of a-SMAþ myofibroblasts, we investigated whether
the number of a-SMAþ fibroblasts was altered during wound
healing in the absence of IL-22. Immunostaining of WT and
IL-22 / wounds after wounding revealed a reduction in the
number of a-SMAþ cells in the dermis of small and large
IL-22 / wounds compared with WT wounds (Figure 5a
and data not shown). In addition, we isolated unwounded
skin and day 3 wounded skin from WT and IL-22 / mice
and measured a-SMA mRNA expression by real-time PCR.
Whereas a-SMA mRNA expression increased in response to
wounding in both WT and IL-22 / mice, a-SMA mRNA
expression was significantly reduced in wounds from IL-22-
null mice compared with WT wounds (Figure 5b). These data
suggest that there was a reduction in the number of myofi-
broblasts in the absence of IL-22.
As the reduced number of a-SMAþ fibroblasts could be due
to alterations in the differentiation of fibroblasts into myofi-
broblasts (Barisic-Dujmovic et al., 2010), we investigated
whether IL-22 was sufficient to induce myofibroblast
differentiation. Primary dermal fibroblasts from WT or IL-22-
null mice were treated in vitro with recombinant IL-22 for
48 hours and a-SMA mRNA and protein expression was
quantified. Real-time PCR analysis revealed a nine-fold
increase in a-SMA mRNA expression after the addition of IL-
22 to fibroblasts from both WT or IL-22 / mice (Figure 5c).
In addition, WT cultures displayed an increase in a-SMA
protein as shown via western blotting (Figure 5d). Taken
together, these data suggest that IL-22 promotes myofibroblast
differentiation and function in the skin after wounding. These
data suggest that the lack of myofibroblasts is most likely
responsible for the dermal remodeling defects in IL-22-null
mice.
DISCUSSION
Given the essential functions of the epithelia to protect
mammalian tissues from the external environment, highly
coordinated mechanisms between multiple cell types have
evolved to repair epithelial tissue damage. The recruitment of
immune cells following acute skin injury is essential for
multiple stages of wound healing including keratinocyte
reepithelialization, extracellular matrix deposition, granulation
tissue remodeling, and wound contraction by fibroblasts
(Eming et al., 2007). Although extensive research has
focused on cytokines and growth factors that mediate
keratinocyte reepithelialization, very little is known about
the signals that mediate the cross talk between immune cells
and fibroblasts. Here we identify IL-22 as an essential signal
that mediates communication between immune cells and
fibroblasts in the skin.
Several studies have linked IL-22 to inflammatory condi-
tions in tissues containing epithelial cells such as the thymus,
the colon, and the skin (Zenewicz et al., 2008; Kagami et al.,
2010; Sekikawa et al., 2010; Yamamoto-Furusho et al.,
2010). In vitro studies have suggested that IL-22 induces
keratinocyte proliferation and migration while inhibiting
keratinocyte differentiation (Boniface et al., 2005; Wolk
et al., 2006; Zheng et al., 2007). Our data suggest that the
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loss of IL-22 alone does not cause major defects in early
events involved in skin wound healing, such as immune cell
recruitment or blood vessel formation. Future experiments
examining specific immune cell subsets, blood vessel
architecture, or keratinocyte function in the absence of IL-
22 may reveal functions for this cytokine in additional aspects
of skin wound healing. Furthermore, our experimental system
did not detect defects in keratinocyte function during
wounding in vivo, suggesting that additional signaling
molecules such as FGF7 and EGF (Werner and Grose,
2003) may compensate for a loss of IL-22 in the skin.
Wound models that challenge the wound epidermis, such
as with a stinted wound technique, may reveal a role for IL-22
in keratinocyte function.
Interestingly, our study uncovered a role for IL-22 in
directing fibroblast function during skin wound repair. Fibro-
blasts have several functions that are defective in IL-22 /
mice, leading to abnormal granulation tissue formation,
extracellular matrix protein production, and wound contrac-
tion. These defects are probably due to direct action of IL-22
on fibroblasts, as primary dermal fibroblasts express IL-22Ra
and IL-22 can induce STAT3 phosphorylation in dermal
fibroblasts downstream of the IL-22Ra. Our data show that
IL-22 directly stimulates extracellular matrix gene expression
in primary dermal fibroblasts in vitro, and that IL-22 / mice
lack extracellular matrix components. Future studies will focus
on whether IL-22 also acts on mesechymal cells in the other
organs during acute regeneration.
Furthermore, the defects in ECM production may be
linked to our finding that IL-22 promotes myofibroblast
differentiation. As the number of myofibroblasts is propor-
tional to the rate of wound contraction and the amount of
ECM produced (Gabbiani et al., 1976), the defects in wound
contraction and the delay in ECM production in IL-22 /
mice is likely due to a reduced number of a-SMAþ
myofibroblasts in the wound bed. This study illustrates a
role for IL-22 on mesenchymal cells during cutaneous wound
healing, which to our knowledge is previously unreported.
These data change the paradigm of IL-10 family cytokines as
mediators of epithelial cell biology, showing that IL-22 also
has a key role in mediating immune cell–stromal cell
interactions during tissue repair.
IL-22 signaling may directly or indirectly stimulate the
expression of ECM genes. Although IL-22 can signal via Jak/
STAT, MAPK, and Akt pathways (Lejeune et al., 2002), the
majority of the effects of IL-22 on epithelial cells have been
linked to STAT3. Our work highlights a role for IL-22-induced
STAT3 phosphorylation in dermal fibroblasts. Therefore, it is
possible that IL-22 signaling directly activates the promoters of
Fibronectin, Collagen IIIaI, and Collagen IaI through STAT3
activation. Alternatively, it is possible that IL-22 indirectly
regulates ECM production by regulating myofibroblast
differentiation.
Although IL-22 has been highlighted for its ability to protect
epithelial cells in the liver and colon during inflammation, it
also has been suggested to have a pathogenic role in psoriasis
and collagen-induced arthritis (Wolk et al., 2006; Lowes
et al., 2008; Geboes et al., 2009; Kagami et al., 2010). The
results presented here could help explain some aspects of
IL-22’s pathogenicity, as IL-22 may act on fibroblast-like
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Figure 5. IL-22 induces myofibroblast differentiation. (a) Skin sections of wild-type (WT) and IL-22 / mice 3 days after wounding with 2-mm punch
biopsies were immunostained with antibodies against a-smooth muscle actin (a-SMA). Quantification of a-SMA staining; n¼ 6 mice for each genotype. LE, leading
edge. (b) Real-time PCR reveals reduced messenger RNA (mRNA) expression of a-SMA in 2-mm IL-22 / wounds 3 days post wounding. n¼4 mice for each
genotype and each time point. (c) Real-time PCR analysis of WT or IL-22 / primary dermal fibroblasts cultured with vehicle or recombinant IL-22 for 48 hours
confirms that a-SMA mRNA expression increases with IL-22 stimulation. n¼3 independent experiments. (d) a-SMA protein expression increases in primary
fibroblasts after stimulation with IL-22 for 48 hours as indicated by a representative image of western blot analysis. Quantification of the ratio of a-SMA/b-actin
expression is shown. n¼ 3 independent experiments. All data are mean±SEM.
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chondrocytes in the joints and fibroblasts in the skin to induce
excessive collagen production in patients with rheumatoid
arthritis or psoriasis, respectively (Koivukangas et al., 1995;
Steenvoorden et al., 2006). In fact, IL-22 was recently shown
to worsen synovitis by inducing the production of RANKL
from synovial fibroblasts and therefore indirectly promoting
osteoclastogenesis (Kim et al., 2012). IL-22 was also shown to
have a role in the pathogenesis of systemic sclerosis, which is
consistent with our data (Truchetet et al., 2011).
Although normal levels and kinetics of IL-22 can enhance
wound healing by inducing myofibroblast differentiation and
ECM production, these physiologic processes may become
pathogenic if excessive ECM production destroys normal
tissue architecture and interferes with organ function (Jun
and Lau, 2010a, b). Therefore, further studies on the role of IL-
22 in conditions characterized by abnormal wound healing,
such hypertrophic scarring and fibrotic diseases, will clarify the
role of IL-22 in the pathogenesis of diseases characterized by
defects in fibroblast-mediated tissue repair (Kong et al., 2012).
MATERIALS AND METHODS
Mice
IL-22 / mice were generated using the VelociGene method
(VelociGene Allele Identification Number: VG204) in collaboration
with Regeneron Pharmaceuticals (Valenzuela et al., 2003). K14-
H2BGFP mice were described previously (Tumbar et al., 2004). For
wounding studies, 7–8-week-old male mice were used during the
telogen phase of the hair cycle. Littermates and C57BL/6 (B6) mice
were used as WT controls. A maximum of four wounds were made on
the dorsal skin of each mouse. All animal care and experimental
procedures were approved by the Yale University Animal Resource
Center and were conducted in accordance with requirements approved
by the Institutional Animal Care and Use Committee of Yale University.
Skin wounding and morphogenetic measurements
WT and IL-22 / mice were anesthetized with isofluorane, and full-
thickness wounds were made on shaved dorsal skins using sterile
dermal biopsy punches, 2, 4, and 8 mm, as indicated (Accuderm, Fort
Lauderdale, FL). Wounds were air-exposed throughout the healing
process. Images of the external appearance of the wounds were taken
and the area of wound was measured using the ImageJ software (NIH,
Bethesda, MD).
To measure histological characteristics of wounds, each wound was
embedded and sectioned through its entirety. Sections from the middle
of the wound, as indicated by the largest length of hyperproliferative
epidermis, were used for all analyses. We determined the percentage
of epidermal reepithelialization by measuring the total length of the
hyperproliferative keratinocyte region and dividing by the total wound
length (the sum of the lengths of the epithelium and unepithelialized
dermis; Qiu et al., 2003). The maximal rate of wound closure was
calculated using linear regression of the epithelialization data.
For rescue experiments, 20ml of phosphate-buffered saline (PBS) or
recombinant IL-22 (25 ng ml 1, R&D Systems, Minneapolis, MN) was
injected intradermally at day 3 post injury. The wound bed area was
determined at the indicated time points after wounding, using the
ImageJ software.
For FACS, RNA, and protein analysis, a circular areaB1 mm larger
than the wound was isolated at the indicated time points in order to
ensure that activated dermal fibroblasts in the wound margins were
included.
Gene expression analysis
Quantitative real-time PCR was performed as previously described
(Horsley et al., 2008; O’Connor et al., 2009). The following accession
numbers were used for the Taqman primers: Mm00444241_m1 (IL-
22) and Mm00663697_m1 (IL-22Ra). For quantitative PCR using
SYBR green, the following primers were used: b-actin For 50-ATC
AAG ATC ATT GCT CCT CCT GAG-30, Rev 50-CTG CTT GCT GAT
CCA CAT CTG-30; Fibronectin For: 50-CTA CCC TGC AGC CTC TGC
GC-30, Rev: 50-TCA CCT CCC TGG CTC GGT CG-30; Collagen IIIaI
For: 50-CTG GTC CTG TTG GTC CAT CT-30, Rev: 50-CTT CTC CAG
CGG TAC CAG AG-30; Collagen IaI For: 50-ACG TCC TGG TGA AGT
TGG TC-30, Rev: 50-TCC AGC AAT ACC CTG AGG TC-30; MMP-9
For: 50-ATC CCC AGA GCG TCA TTC GCG-30, MMP-9 Rev: 50-CAC
GTA GCC CAC GTC GTC CAC-30; a-SMA For: 50-GTC CCA GAC
ATC AGG GAG TAA-30, Rev: 50-TCG GAT ACT TCA GCG TCA
GGA-30; CD45 For: 50-TAC GCA AAG CAC GGC CTG GG-30, Rev:
50-CTC CGG GGT TCC CAC CCC TC-30; Vimentin For: 50-CAG GGC
AGC AGT GAG GTC-30, Rev: 50-TCC TCG AGC AGC AGA ACA
AAA TCC-30.
Dermal fibroblast isolation and IL-22 stimulation
Primary dermal fibroblasts were isolated from 8- to 12-week-old mice
using either Collagenase 1A (2.5 mgml 1, Sigma, St Louis, MO) and
DNaseI (62.5 U ml 1, Sigma) digestion or tail skin explant cultures.
After skin digestion, isolated cells were centrifuged after filtering and
plated with high-glucose DMEM (Invitrogen, Grand Island, NY)
containing 10% fetal bovine serum and 1% Penicillin/Streptomycin/
Amphotericin. Fibroblasts were grown to 85% confluence and
recombinant IL-22 (R&D Systems) was added at indicated doses (10
or 20 ng ml 1) for 48 hours. Cells were harvested in Trizol for RNA
extraction, and cell lysates were harvested in radioimmuno precipita-
tion assay buffer for western blot analysis.
Isolation, culture, and analysis of primary fibroblasts
Primary dermal fibroblasts were isolated from the wounded skin of
12-week-old mice using Collagenase 1A (2.5 mg ml 1, Sigma) and
DNaseI (62.5 U ml 1, Sigma) digestion. After filtering the digested
tissue with a 70-mm2 mesh, cells were centrifuged and if cultured,
plated in DMEM media containing glucose, 10% fetal bovine serum
and 1% Pen/Step/Amphotericin. For FACS analysis, freshly isolated
cells were fixed, permeablized, and stained with rat a-ER-TR7
(1:250, Novus Biologicals, Littleton, CO) and Alexa 488–conjugated
a-rabbit IgG (1:250, Invitrogen). Samples were analyzed on a
FACS Aria and analyzed with the FlowJo software (Tree Star Inc.,
Ashland, OR).
Western blotting
To collect protein lysates from wounds in vivo, wounded skin was
isolated and flash-frozen in liquid N2. Skin was minced and added to
radioimmuno precipitation assay buffer (50 mM Tris, 150 mM NaCl,
0.1% SDS, 0.5% Na Deoxycholate, 1% NP-40) containing protease
inhibitors (Roche, Indianapolis, IN). The tissue was homogenized,
sonicated for 10 minutes, and frozen at –80 1C. To collect protein
lysates from cell culture, cells were washed once with PBS (Invitro-
gen) and then lysed with radioimmuno precipitation assay buffer.
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Total protein was measured using the Bradford assay, and 10mg of
protein was run on 4–20% Tris-Glycine gels (Invitrogen) before being
transferred to nitrocellulose membranes. Membranes were blocked
with blocking buffer (5% nonfat dry milk, 10 mM Tris, 100 mM NaCl,
0.1% Tween-20) and probed with the following primary antibodies:
Rabbit polyclonal a-STAT3 (1:1,000, Cell Signaling Technology,
Danvers, MA), murine monoclonal a-STAT3-P (1:1,000 Cell Signal-
ing), murine monoclonal a-Fibronectin (Calbiochem, San Diego, CA),
goat polyclonal a-alpha-SMA (Sigma), murine monoclonal a-b-actin
(1:20,000, Sigma), and secondary antibodies (1:5,000, peroxidase-
conjugated a-mouse IgG, a-rabbit IgG, and a-goat IgG). Western blots
were visualized via chemiluminescence with the ECL Plus Detection
System (Amersham, Pittsburgh, PA).
Cell sorting
To purify keratinocytes from mouse skin, K14-H2BGFP mice were
shaved and dorsal skins were removed. The dermal side of the skin
was scraped to remove fat and floated on 0.25% trypsin overnight at
4 1C. To release epidermal cells, the dorsal side of the skin was
scraped, cells were filtered, washed in PBS, and resuspended in
PBSþ 3% Serumþ 1% Penicillin/Streptomycin/Amphotericin con-
taining 50mg ml 1 DNaseI. Cells were stained with propidium iodide
a-CD49f-PE (1:75; BD Biosciences, San Jose, CA) antibodies and
CD49fþ , GFPþ , PI keratinocytes were purified via FACS.
To purify naive CD4þ T cells from spleens, splenocytes were
isolated from 6- to 8-week-old C57BL/6 mice and a single-cell
suspension was treated with red blood cell lysis buffer. Cells were
enriched for CD4þ cells (L3T4 microbeads and magnetic-activated
cell sorting columns, Miltenyi Biotech, Auburn, CA). CD4þCD25
CD44CD62Lþ cells were purified by cell sorting on a FACS
Vantage sorter with FITC-conjugated a-CD44, PE-conjugated a-
CD25, APC-conjugated a-CD4, and PECy7-conjugated a-CD62L
(all from BD Biosciences). Sorted cell purity was 497%.
Histological stains and immunofluorescence
Wounded dorsal skins were mounted in OCT compound (Tissue-Tek)
on dry ice and cryosectioned for histological staining or immuno-
staining with the indicated antibodies. For Movat pentachrome and
Sirius Red stains, skin samples were fixed in 10% formalin-buffered
saline, embedded in paraffin, sectioned through the entire length of
the wound, and stained. Trichrome staining was performed using the
Masson’s trichrome staining kit according to the manufacturer’s
protocol (Polysciences, Warrington, PA).
Immunostaining was performed as described previously (Festa
et al., 2011). Briefly, tissue sections were fixed with 4%
formaldehyde and blocked with PBS containing 0.02% Gelatin,
0.25% Triton-X, 1% BSA, and normal goat and donkey serum.
When applicable, the M.O.M. kit (Vector labs, Burlingame, CA)
was used to prevent nonspecific binding of mouse antibodies. Slides
were stained with rat polyclonal a-ER-TR7 (1:250, Novus Biologicals),
rabbit polyclonal N-terminal a-IL-22R (1:250, QED Biosciences, San
Diego, CA), rabbit polyclonal a-phospho-STAT3 (1:100, Cell Signaling),
murine monoclonal a-SMA (1:250, Thermo Scientific, Asheville, NC),
rabbit polyclonal a-Ki67 (1:300, Leica Microsystems, Buffalo Grove, IL),
rat monoclonal CD45-PE-Cy7 (1:500, eBioscience, San Diego, CA),
rabbit polyclonal cathelicidin (1:300, Novus Biologicals), or Isolectin
GS-IB4 Alexa 488–conjugated antibodies (1:100, Invitrogen) overnight
at 4 1C, and then with required secondary antibodies (1:250).
Immunofluorescent staining of fibroblasts was performed on micro-
coverslips in six-well tissue culture plates. Cells were serum-starved
for 24 hours and then treated with 25 ng ml 1 recombinant Oncos-
tatin M (R&D Systems) or 25 ng ml 1 recombinant IL-22 (R&D
Systems) for 20 minutes. Cells were washed and fixed in 4%
formaldehyde before being stained with murine monoclonal a-
STAT3-P (1:100, Cell Signaling). Image acquisition was performed
using a Zeiss confocal microscope or an upright Zeiss microscope
with Axiovision software (Zeiss, Oberkochen, Germany).
Statistical analysis
To determine significance between groups, comparisons were made
using Student’s t-tests. Analyses of multiple groups were performed
using one-way ANOVA with Bonferroni’s post-test with GraphPad
Prism version for Macintosh (GraphPad Software, La Jolla, CA). For all
statistical tests, the 0.05 level of confidence was accepted for statistical
significance.
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